Cash, Cash Equivalents, and Marketable Securities
UnitedHealth Group Cash, Cash Equivalents, and Marketable Securities increased by 0.5% to $46.82B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $46.26B to $46.82B. Over 4 years (FY 2020 to FY 2024), Cash, Cash Equivalents, and Marketable Securities shows an upward trend with a 4.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher levels indicate strong liquidity and financial health, while lower levels may signal a need for external financing.
Detailed definition
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term invest...
Peer comparison
A standard liquidity metric reported by virtually all public companies on the balance sheet.
cash_equivalents_marketable_securities_totalHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.13B | $42.76B | $40.22B | $39.84B | $40.00B | $39.55B | $42.32B | $45.38B | $44.13B | $44.35B | $44.90B | $44.13B | $44.73B | $46.26B | $46.92B | $46.45B | $46.61B | $46.82B |
| QoQ Change | — | +1.5% | -5.9% | -0.9% | +0.4% | -1.1% | +7.0% | +7.2% | -2.8% | +0.5% | +1.2% | -1.7% | +1.4% | +3.4% | +1.4% | -1.0% | +0.3% | +0.5% |
| YoY Change | — | — | — | — | -5.0% | -7.5% | +5.2% | +13.9% | +10.3% | +12.1% | +6.1% | -2.8% | +1.4% | +4.3% | +4.5% | +5.2% | +4.2% | +1.2% |
Cash, Cash Equivalents, and Marketable Securities at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's cash, cash equivalents, and marketable securities?
- UnitedHealth Group (UNH) reported cash, cash equivalents, and marketable securities of $46.82B in Q3 2025.
- How has UnitedHealth Group's cash, cash equivalents, and marketable securities changed year-over-year?
- UnitedHealth Group's cash, cash equivalents, and marketable securities increased by 1.2% year-over-year, from $46.26B to $46.82B.
- What is the long-term trend for UnitedHealth Group's cash, cash equivalents, and marketable securities?
- Over 4 years (2020 to 2024), UnitedHealth Group's cash, cash equivalents, and marketable securities has grown at a 4.2% compound annual growth rate (CAGR), from $39.83B to $46.92B.
- What does cash, cash equivalents, and marketable securities mean?
- The total value of the company's cash and highly liquid short-term investments.